Gene Expression and Mutation Analysis (GEMA) –Guided Precision Medicine Targeting PARP1 to Induce Synthetic Lethality in DNA-PK –Deficient Quiescent and BRCA-Deficient Proliferating Leukemia Stem and Progenitor Cells
Margaret Nieborowska-Skorska(Temple University), Tomasz Skórski(Temple University), Chun Zhou(Guangdong Pharmaceutical University), Kolja Eppert(Ontario Institute for Cancer Research), Grażyna Hoser(Postgraduate School of Molecular Medicine), Mark D. Minden(University Health Network), Curt I. Civin(University of Maryland, Baltimore), Markus Müschen(Yale Cancer Center), Artur Słupianek(Temple University), Sabine Cerny‐Reiterer(Medical University of Vienna), Stephen M. Sykes(Fox Chase Cancer Center), Paulina Podszywalow‐Bartnicka(Yale University), Elisabeth Bolton-Gillespie(Temple University), Tomasz Stokłosa(Medical University of Warsaw), Peter Valent(Medical University of Vienna), Katherine Sullivan(Temple University), Kimberly Cramer-Morales(Temple University)
Cited by 2
Related Papers
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k
Acetylation of the p53 DNA-Binding Domain Regulates Apoptosis Induction
|Molecular Cell|2006|747